BioLife Solutions Inc.’s recent filing unveils that its Chief Executive Officer Rice Michael unloaded Company’s shares for reported $19002.0 on Aug 25. In the deal valued at $10.99 per share,1,729 shares were sold. As a result of this transaction, Rice Michael now holds 416,906 shares worth roughly $ 5.59 million.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Then, Wichterman Troy sold 585 shares, generating $6,429 in total proceeds. Upon selling the shares at $10.99, the Chief Financial Officer now owns 65,933 shares.
Before that, Mathew Aby J. sold 519 shares. BioLife Solutions Inc. shares valued at $5,704 were divested by the EVP & Chief Scientific Officer at a price of $10.99 per share. As a result of the transaction, Mathew Aby J. now holds 271,220 shares, worth roughly $3.63 million.
Craig Hallum initiated its BioLife Solutions Inc. [BLFS] rating to a Buy in a research note published on Friday, July 11, 2023; the price target was $29. PT values the company’s stock at a premium of 53.79 to its Friday closing price.
Price Performance Review of BLFS
On Friday, BioLife Solutions Inc. [NASDAQ:BLFS] saw its stock jump 1.44% to $13.40. On the same session, the stock had its day’s lowest price of $13.25, but rose to a high of $13.66. Over the last five days, the stock has gained 22.71%. BioLife Solutions Inc. shares have fallen nearly -26.37% since the year began. Nevertheless, the stocks have fallen -43.24% over the past one year. While a 52-week high of $26.96 was reached on 02/06/23, a 52-week low of $10.48 was recorded on 08/21/23. SMA at 50 days reached $17.47, while 200 days put it at $20.35. A total of 0.36 million shares were traded, compared to the trading of 0.67 million shares in the previous session.
Levels Of Support And Resistance For BLFS Stock
The 24-hour chart illustrates a support level at 13.21, which if violated will result in even more drops to 13.03. On the upside, there is a resistance level at 13.62. A further resistance level may holdings at 13.85. The Relative Strength Index (RSI) on the 14-day chart is 43.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.42, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 8.18%. Stochastics %K at 93.36% indicates the stock is a selling.
How much short interest is there in BioLife Solutions Inc.?
A steep rise in short interest was recorded in BioLife Solutions Inc. stocks on Aug 14, 2023, dropping by 80000.0 shares to a total of 3.01 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 3.09 million shares. There was a decline of -2.66%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 10.17% of the overall stock float, the days-to-cover ratio (short ratio) fell to 7.13.
BioLife Solutions Inc. [BLFS] – Who Are The Largest Shareholders?
In filings from Casdin Capital LLC, it is revealed that the company now owns 7,780,000 shares, or roughly 17.89% of the outstanding BLFS shares. In other words, the investor’s shares have risen by 58,465 from its previous 13-F filing of 7721535.0. Additionally, BlackRock Fund Advisors increased 0.87% of its stake after which the total value it holdings stand at $100,117,628, while The Vanguard Group, Inc. added 1.28% of its stake to hold $49.04 million in the firm. Over the last quarter, Park West Asset Management LLC purchased 627,954 shares of BioLife Solutions Inc., while Fred Alger Management LLC bought 147,899 shares. At present, Geneva Capital Management LLC is holding 1,561,443 shares valued at $31.04 million. SSgA Funds Management, Inc. owned 1,153,873 shares of the company at the time of its most recent 13F filing, worth $22.94 million.
According to FactSet, BioLife Solutions Inc.’s share price will average $25.14 in the next year, based on opinions of analysts polled by the firm. This is up nearly 89.25 percent from its previous closing price of $13.21. Analysts expect BioLife Solutions Inc. stock to reach the higher price of $30.00, while the lowest price estimate is $22.00. However, 8 analysts have rated BLFS stock as a Buy in their predictions for 2023.